Suven Pharmaceuticals (India) Today

SUVENPHAR -  India Stock  

INR 531.20  15.50  3.01%

Suven Pharmaceuticals is trading at 531.20 as of the 28th of October 2021. This is a 3.01 percent increase since the beginning of the trading day. The stock's open price was 515.7. Suven Pharmaceuticals has about a 24 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Suven Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of August 2021 and ending today, the 28th of October 2021. Click here to learn more.
 Market Performance
0 of 100
  Odds Of Distress
Less than 24
Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. Suven Pharmaceuticals Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited. Suven Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in India and is traded on National Stock Exchange of India. The company has 254.56 M outstanding shares. More on Suven Pharmaceuticals
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Suven Pharmaceuticals Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Suven Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Suven Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Suven Pharmaceuticals generated a negative expected return over the last 90 days
About 62.0% of the company outstanding shares are owned by corporate insiders
Legal NameSuven Pharmaceuticals
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Suven Pharmaceuticals' available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellOvervalued
Suven Pharmaceuticals (SUVENPHAR) is traded on National Stock Exchange of India in India and employs 1,114 people. The company currently falls under 'Mega-Cap' category with current market capitalization of 137.11 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Suven Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Suven Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Suven Pharmaceuticals operates under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 254.56 M outstanding shares.
Check Suven Pharmaceuticals Probability Of Bankruptcy
Ownership
Suven Pharmaceuticals shows a total of two hundred fifty-four million five hundred sixty thousand outstanding shares. Suven Pharmaceuticals has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company outstanding shares. 62.39 % of Suven Pharmaceuticals outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how much assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check Suven Ownership Details

Suven Stock Price Odds Analysis

What are Suven Pharmaceuticals' target price odds to finish over the current price? In reference to a normal probability distribution, the odds of Suven Pharmaceuticals jumping above the current price in 90 days from now is about 41.9%. The Suven Pharmaceuticals probability density function shows the probability of Suven Pharmaceuticals stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Suven Pharmaceuticals has a beta of -0.2416. This usually implies as returns on benchmark increase, returns on holding Suven Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, however, Suven Pharmaceuticals is likely to outperform the market. Additionally, the company has an alpha of 0.101, implying that it can generate a 0.1 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Odds Down 531.2HorizonTargetOdds Up 531.2 
57.88%90 days
 531.20 
41.90%
Based on a normal probability distribution, the odds of Suven Pharmaceuticals to move above the current price in 90 days from now is about 41.9 (This Suven Pharmaceuticals probability density function shows the probability of Suven Stock to fall within a particular range of prices over 90 days) .

Suven Pharmaceuticals Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Suven Pharmaceuticals market risk premium is the additional return an investor will receive from holding Suven Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Suven Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Suven Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Suven Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.

Suven Stock Against Markets

Picking the right benchmark for Suven Pharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Suven Pharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Suven Pharmaceuticals is critical whether you are bullish or bearish towards Suven Pharmaceuticals at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Suven Pharmaceuticals without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Financial Widgets Now

   

Financial Widgets

Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
All  Next Launch Module
Additionally, take a look at World Market Map. Note that the Suven Pharmaceuticals information on this page should be used as a complementary analysis to other Suven Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Tools for Suven Stock

When running Suven Pharmaceuticals price analysis, check to measure Suven Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Suven Pharmaceuticals is operating at the current time. Most of Suven Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Suven Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Suven Pharmaceuticals' price. Additionally, you may evaluate how the addition of Suven Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go